Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS, (UNAUDITED)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS, (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 142,000 413,000 356,000 945,000
Research and development expenses 60,000 157,000 107,000 227,000
Loss before other expense (202,000) (570,000) (463,000) (1,172,000)
Other expense        
Interest and financing expense (72,000) (271,000) (182,000) (435,000)
Net Loss $ (274,000) $ (841,000) $ (645,000) $ (1,607,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.01)
Weighted average common shares outstanding, basic and diluted 326,479,089 314,950,397 324,832,480 313,007,039